Do you want to read an article? Please log in or register.
Impact of HIV infection on the course of inflammatory bowel disease and drug safety profile: a multicenter GETAID study
HIV / AIDS
Related content
SPECIAL REPORT
HIV / AIDS
11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021
HIV / AIDS
Prevalence of potential drug-drug interactions in patients of the Swiss HIV Cohort Study in the era of HIV integrase inhibitors
Clin Infect Dis.
Deutschmann E, Bucher HC, Jaeckel S, Gibbons S, McAllister K, Scherrer AU, Braun DL, Cavassini M, Hachfeld A, Calmy A, Battegay M, Cipriani M, Elzi L, Young J, Lopez-Centeno B, Berenguer J, Khoo S, Moffa G, Marzolini C, Swiss HIV Cohort Study.
doi: 10.1093/cid/ciaa918.
HIV / AIDS
Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial
Lancet HIV.
Eron JJ Jr, Lelievre JD, Kalayjian R, Slim J, Wurapa AK, Stephens JL, McDonald C, Cua E, Wilkin A, Schmied B, McKellar M, Cox S, Majeed SR, Jiang S, Cheng A, Das M, SenGupta D
doi: 10.1016/S2352-
HIV / AIDS
Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA
HIV Med.
Mills AM, Schulman KL, Fusco JS, Brunet L, Hsu R, Beyer A, Prajapati G, Mounzer K, Fusco GP
doi: 10.1111/hiv.12826.
RECOMMENDED
Viral Infections, Non-HIV
Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
doi: 10.1093/ecco-jcc/jjaa061.
HIV / AIDS
Repeated Syphilis Episodes in HIV-Infected Men Who Have Sex With Men: A Multicenter Prospective Cohort Study on Risk Factors and the Potential Role of Syphilis Immunity
Open Forum Infect Dis.
Roth JA, Franzeck FC, Balakrishna S, Lautenschlager S, Thurnheer MC, Trellu LT, Cavassini M, Vernazza P, Bernasconi E, Braun D, Kouyos RD, Battegay M, Swiss HIV Cohort Study (SHCS)
doi: 10.1093/ofid/ofaa019.
HIV / AIDS
Antiretroviral Drugs Associated with Subclinical Coronary Artery Disease in the Swiss HIV Cohort Study
Clin Infect Dis.
Kovari H, Calmy A, Doco-Lecompte T, Nkoulou R, Marzel A, Weber R, Kaufmann PA, Buechel RR, Ledergerber B, Tarr PE; Swiss HIV Cohort Study
doi: 10.1093/cid/ciz283.
HIV / AIDS
Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017
HIV Med.
Hampel B, Kusejko K, Kouyos RD, Böni J, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Nicca D, Schmidt AJ, Nguyen H, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Braun DL, Fehr J, Swiss HIV Cohort Study group.
doi: 10.1111/hiv.12821.
HIV / AIDS
Aging does not impact drug-drug interaction magnitudes with antiretrovirals: a Swiss HIV Cohort Study
AIDS.
Stader F, Decosterd L, Stoeckle M, Cavassini M, Battegay M, Saldanha SA, Marzolini C, Courlet P, and the Swiss HIV Cohort Study
doi: 10.1097/QAD.0000000000002489.